Kovina Therapeutics
Indianapolis, US · Founded 2020 · Delaware corporation · 2 known investors
Kovina develops first-in-class small molecule antiviral drugs to treat HPV-induced cancers and premalignant infections such as cervical and anal dysplasia. The company aims to offer non-surgical treatment options for patients living with HPV.
Founders & leadership
Kovina Therapeutics was founded in 2020 by Elliot Androphy.
EA
Elliot AndrophyinChief Scientific Officer
KS
Kristin ShermanChief Executive Officer, President and Treasurer
WR
William RingoNamed on SEC filing
TW
Teri WilleyNamed on SEC filing
SM
Susan MahonyNamed on SEC filing
Board
FF
Fritz FrenchChairman of the Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2021
▶$2MraisedJul 2021 · 11 investors · BiotechnologyRule 506(b)
▶$2MraisedJul 2021 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William RingoDirector
- Elliot AndrophyExecutive Officer, Director
- Teri WilleyDirector
- Fritz FrenchExecutive Officer, Director
- Kristin ShermanExecutive Officer, Director
- Susan MahonyDirector
- Offering amount
- $2.5M
- Amount sold
- $2M
- Minimum investment
- $50K
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapCullinan Therapeutics6 shared keywordsCullinan Therapeutics is a clinical-stage biotechnology company developing therapies for autoimmune diseases and cancer, with a pipeline that includes CD19- and BCMA-targeted T cell engagers. Its focus areas include immune modulation approaches for conditions such as refractory lupus (SLE) and rheumatoid arthritis.
Kura Oncology5 shared keywordsKura Oncology is a company in the oncology/medtech sector that provides grant support for independent medical education programs designed to enhance healthcare professionals' ability to diagnose and treat patients in Kura Oncology's therapeutic areas of interest.
Companies competing with Kovina Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Kovina Therapeutics do?
- Kovina develops first-in-class small molecule antiviral drugs to treat HPV-induced cancers and premalignant infections such as cervical and anal dysplasia. The company aims to offer non-surgical treatment options for patients living with HPV.
- Who founded Kovina Therapeutics?
- Kovina Therapeutics was founded by Elliot Androphy in 2020.
- Who are Kovina Therapeutics's investors?
- Kovina Therapeutics's investors include Elevate Ventures, IU Ventures.
- How much funding has Kovina Therapeutics raised?
- Kovina Therapeutics has disclosed $2M raised across 1 round.
- Where is Kovina Therapeutics headquartered?
- Kovina Therapeutics is headquartered in Indianapolis, US.